Home › Compare › Cagrilintide vs Eloralintide
Cagrilintide vs Eloralintide
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
CagrilintideMetabolic / Weight Loss
EloralintideMetabolic / Weight LossAt a glance
| Cagrilintide | Eloralintide | |
|---|---|---|
| Category | Metabolic / Weight Loss | Metabolic / Weight Loss |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Appetite suppression Fullness Fat loss (esp. with GLP-1) | Appetite suppression Prolonged satiety Weight loss (gradual, over weeks) Improved glycemic control |
| Reported considerations | Nausea Injection site reaction | Nausea (usually mild, transient) Vomiting (rare at low doses) Injection site reaction |
The differences that actually matter
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Where they overlap: appetite suppression, fat loss (esp. with glp-1).
Reported mainly for Cagrilintide: fullness.
Reported mainly for Eloralintide: prolonged satiety, improved glycemic control.
What Cagrilintide is
Cagrilintide is a synthetic, long-acting analog of the naturally occurring hormone amylin, which is co-secreted with insulin from pancreatic beta cells. It primarily functions by activating amylin receptors, which are complexes of the calcitonin receptor with receptor activity-modifying proteins (RAMPs 1, 2, or 3), found in various tissues, including the brain. Through this mechanism, cagrilintide influences satiety centers in the hypothalamus and slows the rate of gastric emptying, thereby reducing post-meal gluco
What Eloralintide is
Eloralintide (LY3841136) is Eli Lilly's investigational selective amylin receptor agonist, engineered to activate the AMY1 receptor with approximately 12-fold greater potency than the calcitonin receptor. Amylin is a pancreatic satiety hormone co-secreted with insulin; by mimicking its action in appetite-control pathways of the hypothalamus, eloralintide increases feelings of fullness, reduces caloric intake, and slows gastric emptying — the three central pillars of amylin-driven weight regulation.
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Cagrilintide and Eloralintide are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Cagrilintide and Eloralintide?
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log Cagrilintide and Eloralintide in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Cagrilintide or Eloralintide?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.